(1) If a confirmatory drug test is conducted on Sample B of a body sample, the notices specified in subregulation 99.210(1) and (3) must be given in respect of that test.
(2) The notices must be given in the form and within the timeframes required by regulation 99.210.
(3) The written notice to the donor must contain the following:
(a) the sample identifier for Sample A and Sample B;
(b) a statement that Sample B was tested;
(c) a statement as to whether the tamper-evident seals on the specimen tubes containing the body sample were intact on receipt by the approved laboratory that tested them;
(d) the list of testable drugs that were tested for;
(e) the date and time that Sample B was tested;
(f) the method used for the testing;
(g) the target concentrations of the testing;
(h) the result of the test;
(i) a statement about whether the sample has been tested in accordance with these Regulations and any conditions attached to the laboratory's National Association of Testing Authorities accreditation.